Literature DB >> 9200489

Clonal expansion of CD8+ T cells in Kawasaki disease.

I H Choi1, Y J Chwae, W S Shim, D S Kim, D H Kwon, J D Kim, S J Kim.   

Abstract

Kawasaki disease (KD) is the major cause of acquired heart disease in children. KD is suspected of being an infectious disease, but the etiology has not yet been clarified. Immunologically, the disease is associated with the activation of T cells, monocytes, and macrophages resulting in highly elevated levels of several cytokines. Recently, expansions of T cells expressing TCRBV2 and TCRBV8 chains have been reported, and this suggests the involvement of a superantigen in the pathogenesis of KD. To address the role of a superantigen in KD, we investigated clonal expansion of T cells by estimating the complementarity-determining region 3 size profile among T cells expressing TCRBV1, TCRBV2, TCRBV4, TCRBV5, TCRBV8, TCRBV14, TCRBV16, TCRBV17, TCRBV18, and TCRBV20 chains during acute KD, during subacute KD, and during the long term follow-up period. During the acute phase of KD, several clonal expansions were found mainly in the CD8+ T cells that disappeared during the long term follow-up period. Our data suggest that the conventional Ags rather than a superantigen were involved in the pathogenesis of acute KD.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9200489

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

Review 1.  Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease.

Authors:  T Matsubara; T Ichiyama; S Furukawa
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

2.  Decreased interferon-gamma (IFN-gamma)-producing T cells in patients with acute Kawasaki disease.

Authors:  T Matsubara; K Katayama; T Matsuoka; M Fujiwara; M Koga; S Furukawa
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

3.  Polyclonal expansion of TCRBV2- and TCRBV6-bearing T cells in patients with Kawasaki disease.

Authors:  T Yoshioka; T Matsutani; S Iwagami; T Toyosaki-Maeda; T Yutsudo; Y Tsuruta; H Suzuki; S Uemura; T Takeuchi; M Koike; R Suzuki
Journal:  Immunology       Date:  1999-03       Impact factor: 7.397

4.  Recent advances in the understanding and management of kawasaki disease.

Authors:  Anne H Rowley; Stanford T Shulman
Journal:  Curr Infect Dis Rep       Date:  2010-03       Impact factor: 3.725

Review 5.  Kawasaki disease: novel insights into etiology and genetic susceptibility.

Authors:  Anne H Rowley
Journal:  Annu Rev Med       Date:  2011       Impact factor: 13.739

Review 6.  Kawasaki disease.

Authors:  Dong Soo Kim
Journal:  Yonsei Med J       Date:  2006-12-31       Impact factor: 2.759

Review 7.  Is Kawasaki disease an infectious disorder?

Authors:  Anne H Rowley
Journal:  Int J Rheum Dis       Date:  2017-11-03       Impact factor: 2.454

8.  CTLA-4 (CD152) expression in peripheral blood T cells in Kawasaki disease.

Authors:  T Matsubara; R Anwar; M Fujiwara; T Ichiyama; S Furukawa
Journal:  Clin Exp Immunol       Date:  2003-04       Impact factor: 4.330

Review 9.  Kawasaki syndrome.

Authors:  A H Rowley; S T Shulman
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

10.  Immunoglobulin V(H) chain gene analysis of peripheral blood IgM-producing B cells in patients with Kawasaki disease.

Authors:  Hyun Hee Lee; In Ho Park; Jeon-Soo Shin; Jun Soo Shin; Dong Soo Kim
Journal:  Yonsei Med J       Date:  2009-08-19       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.